Literature DB >> 29909523

Synthesis and Cytotoxicities of Royleanone Derivatives.

Cheng-Ji Li1,2, Fan Xia1,2, Rong Wu3, Hong-Sheng Tan3, Hong-Xi Xu4, Gang Xu5, Hong-Bo Qin6.   

Abstract

Carnosic acid was used as starting material to synthesize royleanone derivatives featured C11-C14 para quinone. The importance of C-20 group of royleanone derivatives was verified by the cytotoxicity assay of royleanonic acid, miltionone I and deoxyneocrptotanshinone. Following our synthetic route, 15 amide derivatives were synthesized and 8 compounds exhibited moderate cytotoxic activities against three human cancer lines in vitro.

Entities:  

Keywords:  Cytotoxicity; Royleanones; para benzoquinone

Year:  2018        PMID: 29909523      PMCID: PMC6224808          DOI: 10.1007/s13659-018-0173-y

Source DB:  PubMed          Journal:  Nat Prod Bioprospect        ISSN: 2192-2209


Introduction

Royleanones, possessing a characteristic 11,14-para benzoquinone 12-hydroxy abietane skeleton, were first isolated by Handa’s group in 1945 from the roots of Inula royleana as yellow pigment [1]. Their chemical structures have been explicitly established for the first time in 1962 by Edwards by synthesis [2]. Royleanones have shown various pharmacological activities, including antitumor, anti-oxidant, antidiabetic [3-5]. These diterpenoids attracted extensive attentions among synthetic chemists and pharmacologists [6]. Our research interests are largely related to the antitumor molecules, especially tricyclic terpenoids derivatives [7-12]. Tanshinones have the functional group of 11,12 ortho benzoquinone, which can serve as a Michael acceptor at C-14 to cellular nucleophiles such as DNA, RNA, protein and GSH [13]. Hence, tanshinones are potent cytotoxic. Considering the fact that para benzoquinone moiety in royleanones could not act as Michael acceptor, the cytotoxic activity of royleanones would be weak. In fact, royleanones has IC50 of 32.5 µM to MIAPaCa-2 cell line and deoxyneocryptotanshinone was inactive (IC50 > 100 µM) to the same cell line [4]. Royleanonic acid was also inactive to K562 human leukemia cell line. However, columbaridione showed potent cytotoxic activity to K562 at 10 µM (Fig. 1) [14]. The difference might attribute to the free acid group and there must be unsolved mechanism other than the Michael acceptor conception because the C-14 was blocked in royleanones. Studies on the structure–activity relationship of royleanon derivatives are rare. Therefore, investigations on the para benzoquinone derivatives might lead to more potent analogues than columbaridione.
Fig. 1

Structures of royleanone derivatives

Structures of royleanone derivatives We focused on the C-20 carbonic acid group of royleanonic acid. It could be transformed into amide derivative because the C-20 is important to maintain the cytotoxicity from above analysis. Therefore, we chose carnosic acid as starting material and then transformed into para benzoquinone. As a result, 15 new amide derivatives were synthesized (Scheme 1). Subsequently, these compounds were tested against three human cancer cell lines (HepG2, MCF 7 and A549). Amide derivatives showed potent antitumor activities.
Scheme 1

Synthetic route of target compounds. Reagents and conditions: a EDCI, DMAP, DCM, rt, 3 h; 95%, b MOMCl, DIPEA, DCM, rt, 12 h; 88%, c Amine or hydrazine, THF, rt, 0.5–5 h; 90%, d m-CPBA, NaHCO3, DCM, rt, 16 h; 45%, e HCl, MeOH, rt, 12 h; 60%, f piperidine, THF, rt, 0.5 h; 65%, g MeONa, MeOH, rt, 12 h; 80%, h LiOH, THF, H2O, rt, 2 h, 60%

Synthetic route of target compounds. Reagents and conditions: a EDCI, DMAP, DCM, rt, 3 h; 95%, b MOMCl, DIPEA, DCM, rt, 12 h; 88%, c Amine or hydrazine, THF, rt, 0.5–5 h; 90%, d m-CPBA, NaHCO3, DCM, rt, 16 h; 45%, e HCl, MeOH, rt, 12 h; 60%, f piperidine, THF, rt, 0.5 h; 65%, g MeONa, MeOH, rt, 12 h; 80%, h LiOH, THF, H2O, rt, 2 h, 60%

Results and Discussions

To verify the hypothesis of the importance of C-20, we synthesized royleanonic acid as indicated in Scheme 1. Started from carnosic acid (1), intramolecular esterification occurred to afford lactone 2 with DCC. The 12-hydroxy group was then protected as MOMO ether. After hydrolysis, the resulting free phenol 10 was oxidized into para benzoquinone 11. Liberation of MOMO ether by HCl afforded the desired royleanonic acid. Next, its derivatives without C-20 group, such as miltionone I and deoxyneocryptanshinone, were also prepared. When miltirone was treated with p-TsOH in MeOH, Deoxyneocrptanshinone was obtained in 70% yield (Scheme 2). The possible mechanism involved the Michael addition of MeOH to miltirone at C-14, followed by oxidation and isomerization of vinyl ether into para benzoquinone. Similarly, miltionone I was obtained from 1-oxomiltirone under the same condition. Meanwhile, arucadiol was also isolated which implied the reduction of 1-oxomiltirone. Although its mechanism is not clear yet, this transformation is different with known method of deprotection of ortho dimethoxy group [15].
Scheme 2

Synthetic route to deoxyneocryptanshinone and miltionone I

Synthetic route to deoxyneocryptanshinone and miltionone I The three diterpenoids were subjected to antitumor assay. The results were collected in Table 1. As can be clearly seen in Table 1, royleanonic acid exhibited more potent antitumor activity, which proved the importance of C-20 group. Obviously, the existence of C-20 group is important.
Table 1

Cytotoxicities of compounds against three cancer cell lines (IC50 μM)

CompoundsHep G2MCF 7A549
Royleanonic acid13.4625.9126.80
Miltionone I> 10086.82> 100
Deoxyneocryptanshinone53.1778.9674.28
2 11.124.2418.04
4a 41.6311.87> 100
4b 35.5450.4639.07
4c 67.5665.7664.56
4d 72.2949.5348.39
4e 52.7270.0474.81
4f > 100> 100> 100
5b 7.9619.9237.88
5c 44.75> 100> 100
5d 7.2817.8132.87
6b 3.9314.9016.48
6c 6.188.3719.11
6d 5.7410.5317.76
6e 7.813.1623.74
6 g28.3582.78> 100
7 1.022.0324.26
9 24.9026.8462.70
STSa0.040.100.01

aPositive control

Cytotoxicities of compounds against three cancer cell lines (IC50 μM) aPositive control Hence, following this route in Scheme 1, several amide derivatives were synthesized using amines to open lactone. All the synthesized compounds were evaluated for cytotoxicity against three human cancer cell lines (HepG2, MCF 7 and A549). Eight royleanone derivatives showed potent cytotoxicity against three human cancer cell lines (IC50 < 10 μM) (Table 1). It is noteworthy that compound 7 had a significant cytotoxicity toward Hep G2 and MCF 7 human cancer lines in vitro (IC50 1.02–2.03 μM). Our experiments demonstrated that, for the first time, modification of orthoquinone into para benzoquinone have shown antitumor activity. Block of C-14 conjugate addition site did not lead to the drop of cytotoxicity (5b, 5d, 6b–6e). These results may attribute to mechanism other than Michael addition of DNA, RNA etc. [13]. The existence of C-20 amide functional group is important to the cytotoxicity when compared with deoxyneocryptanshinone and miltionone I. Cyclic secondary amine 7 gave the best result. All derivatives are active towards HpeG2 cell line. These findings may serve as new clues for discovering antitumor molecules with new structure scaffold. Below is the link to the electronic supplementary material. Supplementary materials such as experimental procedures, MS and NMR spectra of the synthesized compounds are available in the online version of this article free of charge. Supplementary material 1 (DOC 5423 kb)
  11 in total

1.  Inula royleana DC; its chemistry and pharmacological action.

Authors:  I C CHOPRA; J D KOHLI; K L HANDA
Journal:  Indian J Med Res       Date:  1945-05       Impact factor: 2.375

2.  Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method.

Authors:  Kayoko Miura; Hiroe Kikuzaki; Nobuji Nakatani
Journal:  J Agric Food Chem       Date:  2002-03-27       Impact factor: 5.279

3.  Przewalskin B, a novel diterpenoid with an unprecedented skeleton from Salvia przewalskii maxim.

Authors:  Gang Xu; Ai-Jun Hou; Yong-Tang Zheng; Yu Zhao; Xiao-Li Li; Li-Yan Peng; Qin-Shi Zhao
Journal:  Org Lett       Date:  2007-01-18       Impact factor: 6.005

4.  Przewalskin A: A new C23 terpenoid with a 6/6/7 carbon ring skeleton from Salvia przewalskii maxim.

Authors:  Gang Xu; Ai-Jun Hou; Rui-Rui Wang; Guang-Yu Liang; Yong-Tang Zheng; Ze-Yuan Liu; Xiao-Li Li; Yu Zhao; Sheng-Xiong Huang; Li-Yan Peng; Qin-Shi Zhao
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

5.  In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.

Authors:  M Fronza; R Murillo; S Ślusarczyk; M Adams; M Hamburger; B Heinzmann; S Laufer; I Merfort
Journal:  Bioorg Med Chem       Date:  2011-06-29       Impact factor: 3.641

Review 6.  Reactivity of Diterpenoid Quinones: Royleanones.

Authors:  Diogo Ladeiras; Carlos M Monteiro; Filipe Pereira; Catarina P Reis; Carlos A M Afonso; Patrícia Rijo
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

7.  Cytotoxic diterpenoids from Salvia yunnanensis.

Authors:  Chun-Yan Wu; Yang Liao; Zi-Gang Yang; Xing-Wei Yang; Xiao-Ling Shen; Rong-Tao Li; Gang Xu
Journal:  Phytochemistry       Date:  2014-07-28       Impact factor: 4.072

8.  Hypercohin A, a new polycyclic polyprenylated acylphloroglucinol possessing an unusual bicyclo[5.3.1]hendecane core from Hypericum cohaerens.

Authors:  Xing-Wei Yang; Xu Deng; Xia Liu; Chun-Yan Wu; Xiao-Nian Li; Bin Wu; Huai-Rong Luo; Yan Li; Hong-Xi Xu; Qin-Shi Zhao; Gang Xu
Journal:  Chem Commun (Camb)       Date:  2012-05-10       Impact factor: 6.222

9.  Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity.

Authors:  Laura Guasch; Esther Sala; Miquel Mulero; Cristina Valls; Maria Josepa Salvadó; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Diterpenoids from the Roots of Salvia yunnanensis.

Authors:  Fan Xia; Chun-Yan Wu; Xing-Wei Yang; Xian Li; Gang Xu
Journal:  Nat Prod Bioprospect       Date:  2015-12-14
View more
  1 in total

1.  Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.

Authors:  Xietao Ye; Jiali Liu; Xinyao Yuan; Songhong Yang; Yi Huang; Yan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.